Atrium Therapeutics, Inc. logo RNA - Atrium Therapeutics, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 7
HOLD 9
SELL 0
STRONG
SELL 0
| PRICE TARGET: $25.00 DETAILS
HIGH: $25.00
LOW: $25.00
MEDIAN: $25.00
CONSENSUS: $25.00
UPSIDE: 90.99%
Annual Quarterly
Metric 2025
Revenue
Revenue 18.6
Cost of Revenue 0
Gross Profit 18.6
Operating Expenses
R&D Expenses 53.8
SG&A Expenses 41.7
Other Expenses 0
Operating Expenses 95.4
Operating Income
Operating Income (76.8)
Interest Expense 0
Interest Income 0
Profitability
EBITDA (76.5)
EBIT (76.8)
Income Before Tax (76.8)
Income Tax Expense (0.1)
Net Income (76.7)
Per Share Data
EPS (Basic) -4.48
EPS (Diluted) -4.48
Shares Outstanding 17.1
Metric 2025
Current Assets
Cash & Cash Equivalents 270
Short-Term Investments 0
Net Receivables 0
Inventory 0
Other Current Assets 1.3
Total Current Assets 272.8
Non-Current Assets
Property, Plant & Equipment 5.5
Goodwill 0
Intangible Assets 0
Long-Term Investments 0
Other Non-Current Assets 0
Total Non-Current Assets 5.5
Total Assets 278.4
Current Liabilities
Account Payables 4.4
Short-Term Debt 0
Deferred Revenue 21.6
Other Current Liabilities 3.1
Total Current Liabilities 41.8
Non-Current Liabilities
Long-Term Debt 0
Deferred Tax Liabilities 0
Other Non-Current Liabilities 0.6
Total Non-Current Liabilities 29.3
Total Liabilities 71.1
Stockholders' Equity
Common Stock 0.0
Retained Earnings 0
Accumulated Other Comprehensive Income 0
Total Stockholders' Equity 207.3
Total Liabilities & Equity 278.4
Debt Metrics
Total Debt 3.7
Net Debt (266.3)
Metric 2025
Operating Activities
Net Income (49.5)
Depreciation & Amortization 0.3
Stock-Based Compensation 7.7
Change in Working Capital (0.2)
Other Non-Cash Items 0.7
Operating Cash Flow (41.1)
Investing Activities
Capital Expenditure (1.4)
Acquisitions 0
Purchases of Investments 0
Sales/Maturities of Investments 0
Other Investing Activities 0
Investing Cash Flow (1.4)
Financing Activities
Net Debt Issuance 0
Stock Repurchased 0
Dividends Paid 0
Other Financing Activities 42.6
Financing Cash Flow 42.6
Cash Position
Net Change in Cash 0
Cash at Beginning 0
Cash at End 0
Free Cash Flow (42.6)
Key Metrics 2025
Income Statement
Revenue 18.6
Gross Profit 18.6
Operating Income (76.8)
Net Income (76.7)
EPS (Diluted) -4.48
Balance Sheet
Cash & Equivalents 270
Total Assets 278.4
Total Debt 3.7
Stockholders' Equity 207.3
Cash Flow
Operating Cash Flow (41.1)
Capital Expenditure (1.4)
Free Cash Flow (42.6)